Characterizing Tissue Response to Drug Therapies by Identifying Reliable Spatial Biomarkers With Imaging Mass Cytometry™

Time: 2:30 pm
day: Day Two


  • Employing in-depth multiplexed data for improved disease profiling and stratification, leading to more successful drug development outcomes
  • Simultaneously detecting mRNA and protein on the same tissue for enhanced spatial immune profiling
  • Creating consistent imaging results across varied tissue types, bypassing the complications of cyclic procedures and autofluorescence